Newswire

Rebates should get focus in PBM probe, policy watchers say Proprietary data protections can complicate transparency Bloomberg Law The...

FTC likely to study pharmacy benefit managers Independent pharmacies join criticism of powerful middlemen Bloomberg Law Independent...

Faced with what appears to be an endless increase in prescription drug costs, employers need a clear view into the prices they pay for...

Misaligned incentives, spread pricing, opaque rebates, and specialty distribution models perpetuate extensive customer mistrust in PBMs,...

Indiana News Radio WIBC Last week a pharmaceutical industry expert named Antonio Ciaccia, testified in front of the Indiana General...

How insurers deflect criticism, avoid reform and preserve the status quo. Un-Covered When I was a health insurance communications exec, I...

No insurer has ever made that kind of money in U.S. history. Wendell Potter NOW Just days after a Commonwealth Fund report showed that...